Willem Overwijk

Willem Overwijk

Company: Nektar Therapeutics

Job title: Vice President - Oncology Research


NKTR-255, an Engineered IL-15 That Expands NK Cells & CD8+ T Cells for the Treatment of Cancer 2:00 pm

Exploring the Preclinical Characterization Understanding the Mechanism of Action Discussing Early Clinical Results This seminar will be delivered digitally at the eventRead more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.